Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The Myocardial Ischaemia National Audit Project 2003-2010 by Gale, CP et al.
promoting access to White Rose research papers
White Rose Research Online
eprints@whiterose.ac.uk
Universities of Leeds, Sheffield and York
http://eprints.whiterose.ac.uk/
This is the Author's Accepted version of an article published in the European
Heart Journal, 33 (5)
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/id/eprint/77859
Published article:
Gale, CP, Cattle, BA, Woolston, A, Baxter, PD, West, TH, Simms, AD, Blaxill, J,
Greenwood, DC, Fox, KA and West, RM (2012) Resolving inequalities in care?
Reduced mortality in the elderly after acute coronary syndromes. The Myocardial
Ischaemia National Audit Project 2003-2010. European Heart Journal, 33 (5).
630 - 639. ISSN 0195-668X
http://dx.doi.org/10.1093/eurheartj/ehr381
1Title Resolving inequalities in care? Reduced mortality in the elderly after
acute coronary syndromes. The Myocardial Ischaemia National Audit
Project 2003 - 2010
Authors CP Gale1,2, BA Cattle1, A Woolston1, P Baxter1, TH West1, AD
Simms1, J Blaxill3, DC Greenwood1, KAA Fox4, RM West1
1Centre for Epidemiology and Biostatistics, University of Leeds,
Leeds, UK.
2Department of Cardiology, York Teaching Hospital NHS Foundation
Trust, York, UK
3Department of Cardiology, Leeds Teaching Hospitals NHS Trust,
Leeds, UK
4Centre for Cardiovascular Science, University of Edinburgh, UK.
Correspondence Chris P. Gale
BSc (Hon), MBBS, MRCP, PhD, Dip, M.Ed.
National Institute for Health Research Clinician Scientist Award Senior Lecturer in
Cardiovascular Health Research * and Honorary Consultant Cardiologist^
*Centre for Epidemiology and Biostatistics, Level 8, Worsley building, University of
Leeds, Clarendon Way, West Yorkshire, Leeds, LS2 9JT, UK
^ York Teaching Hospital NHS Foundation Trust, Wigginton Road, York, YO31
8HE, UK
c.p.gale@leeds.ac.uk, Tel: +44(0) 113 343 4890, Fax: +44(0) 113 343 4877
2Study design: Observational study
Ethical approval: The National Institute for Cardiovascular Research
(NICOR) which includes the Myocardial Ischaemia
National Audit project (MINAP) (Ref: NIGB: ECC 1-
06 (d)/2011) has support under section 251 of the
National Health Service (NHS) Act 2006. On seeking
advice from Leeds (West) Research Ethics Committee,
formal ethical approval was not required under NHS
research governance arrangements for the project.
Details of funding: MINAP is funded by the Health Quality Improvement
Partnership (HQIP). This study was funded by the
British Heart Foundation. CPG is funded by the
National Institute for Health Research as a Clinician
Scientist and Honorary Consultant Cardiologist
Conflicts of interest: There were no conflicts of interest
Word count: 3285 (excluding abstract and references)
244 (abstract)
References: 41
Tables: 6
Figures: 1
3Abstract
Aims : To examine age-dependent in-hospital mortality for hospitalization with acute
coronary syndromes (ACS) in England and Wales.
Methods and results : Mixed-effects regression analysis using data from 616011
ACS events at 255 hospitals as recorded in the Myocardial Ischemia National Audit
Project (MINAP) 2003–2010. 102,415 (16.7%) patients were aged <55 years and
72,721 (11.9%) ≥85 years. Patients ≥85 years with ST-elevation myocardial infarction
(STEMI) were less likely to receive emergency reperfusion therapy than those <55
years (RR=0.27, 95% CI: 0.25-0.28). Older patients had greater lengths of stay
(P<0.001) and higher in-hospital mortality (P<0.001). For STEMI and non ST-
elevation myocardial infarction (NSTEMI) there were reductions in in-hospital
mortality from 2003-2010 across all age groups including the very elderly. For
STEMI ≥85 years, in-hospital mortality reduced from 30.1% in 2003 to 19.4% in
2010 (RR=0.54, 95% CI: 0.38-0.75, P<0.001), and for NSTEMI ≥85 years from
31.5% in 2003 to 20.4% in 2010 (RR=0.56, 95% CI: 0.42-0.73, P<0.001). Findings
were upheld after multi-level adjustment (base = 2003): male STEMI 2010 OR=0.60,
95% CI: 0.48-0.75, female STEMI 2010 OR=0.55, 95% CI: 0.42-0.71, male NSTEMI
OR=0.50, 95% CI: 0.42-0.60, female NSTEMI OR=0.49, 95% CI: 0.40-0.59.
Conclusion : For patients hospitalized with ACS in England and Wales, there have
been substantial reductions in in-hospital mortality rates from 2003 to 2010 across all
age groups. The temporal improvements in mortality were similar for sex and type of
acute myocardial infarction. Age-dependent inequalities in the management of ACS
were apparent.
4Key words: Acute coronary syndrome; STEMI; NSTEMI; age; in-hospital mortality;
MINAP; quality of care
5Introduction
Data from international studies suggest that elderly patients who are admitted to
hospital with an acute coronary syndrome (ACS) are less likely to receive evidence-
based care and that they have higher mortality rates than their younger counterparts 1-
7. Recently however, there have been substantial improvements in the treatment and
outcome of ACS among a range of developed and developing countries 8,9. In part,
this has been attributed to increased use of evidence-based ACS therapies 8-11. For the
elderly, it has been advocated that improvements in hospital care may translate into a
reduction in mortality and research has highlighted the need for quality-of-care
programs that reinforce the use of evidence-based therapies among this group 2.
With the advent of the new definition of acute myocardial infarction (AMI) and a
greater emphasis placed on the results of the cardiac troponin concentration 12, a
contemporary analysis of patients admitted to hospital with an ACS may reveal a
changing burden of disease and early outcomes. Moreover, it is not known whether
the effects of reported improvements in ACS care have occurred equally across the
spectrum of ACS ages. This study, therefore, aimed 1) to establish whether, in light of
international recommendations 13,14, age-dependent inequalities in care continue to
exist in a modern national healthcare system, and 2) to quantify and compare temporal
effects in in-hospital mortality by age for patients who present to hospital with an
ACS.
6Methods
Study design
The analyses were based on data from the Myocardial Ischaemia National Audit
Project (MINAP) whose national database was established in 1999 to examine the
quality of management of acute myocardial infarction (AMI) in England and Wales
and to meet the audit requirements of the National Service Framework (NSF) for
Coronary Heart Disease 15-18. MINAP data collection and management has previously
been described 19,20.
Data for patients admitted with an ACS are collected prospectively at each acute
hospital by a secure electronic system, developed by the Central Cardiac Audit
Database (CCAD), electronically encrypted and transferred on-line to a central
database 21. CCAD is part of the National Institute for Cardiovascular Research
(NICOR) based at University College London. MINAP is overseen by a multi
professional steering group representing the stakeholders 16.
Each patient entry offers details of the patient journey, including the method and
timing of admission, in-patient investigations, treatment, and date of all-cause death
(from linkage to the National Health Service Central Register (NHSCR) using a
unique National Health Service (NHS) number). Data entry is subject to routine on-
line error checking. There is a mandatory annual data validation exercise for each
hospital 22.
Ethics
7NICOR which includes the Myocardial Ischaemia National Audit project
(MINAP) (Ref: NIGB: ECC 1-06 (d)/2011) has support under section 251 of the NHS
Act 2006. On seeking advice from Leeds (West) Research Ethics Committee, formal
ethical approval was not required under NHS research governance arrangements for
the study.
Cohort description
The investigators had access to data in which patient identity was protected. The
MINAP cohort comprised 616011 index patient events admitted to 238 acute
hospitals in England and 17 acute hospitals in Wales between 1st January 2003 and 2nd
October 2010.
Ages on admission were categorised into 5 groups: <55 years, 55 to 64 years, 65 to 74
years, 75 to 84 years and ≥85 years of age. The initial diagnosis was based on the
working diagnosis generated by a paramedic or first attending physician who was in a
position to provide definitive treatment. The final diagnosis was formed from the
patients’ presenting history, clinical examination and the results of inpatient
investigations, and made by a senior member of the medical staff. The consensus
document of the Joint European Society of Cardiology / American College of
Cardiology 23 was used as the diagnostic standard for AMI and provided the basis for
categorisation into STEMI. Non ST-elevation acute coronary syndrome (NSTEACS)
was defined as a troponin positive (NSTEMI) or troponin negative (unstable angina)
ACS.
Statistical methods
8The population was described without adjustment and by percentages with respect to
discrete data, and by medians and interquartile range or mean and 95% range for
continuous variables. Pearson’s Chi-squared test was used to determine whether there
was a significant difference between the expected frequencies and the observed
frequencies in one or more categories. The Kruskall-Wallis rank test was used to test
the difference in distributions across groups. The analysis of variance test was use to
ascertain whether the means of several groups were all equal.
Given that there was a significant interaction between age, in-hospital mortality and
sex for STEMI (P<0.001) and NSTEMI (P<0.001), models were fitted by sex. To
account for variations at the hospital level, a linear mixed-effects regression model
was used to quantify the relationship between age category and ACS final diagnosis at
discharge from hospital, and between age category and in-hospital all-cause mortality.
The model fitted included age, history of diabetes, hypertension, previous AMI,
angina, history of heart failure, previous revascularisation (percutaneous coronary
intervention (PCI) and / or coronary artery bypass grafting (CABG)), admitting
consultant, admission ward and emergency reperfusion (primary PCI and / or
thrombolysis). The temporal risk of in-hospital mortality was quantified by STEMI
and NSTEMI after adjustment for age category and consideration of hospital random
effects. Finally, the risk of in-hospital mortality was estimated for each age category
after adjustment for the final diagnosis and consideration of hospital random effects.
We used STATA IC version 11.0 (Stat Corp LP, Texas, USA) for the analyses.
9Results
Of the 616011 patients, 102415 (16.7%) were <55 years and 72721 (11.9%) were ≥85
years of age. Data for age were missing for 4.2% of men and 4.5% of women, and in-
hospital status was missing for 5.6% of the cohort. The proportion of men reduced
from 79.4% among patients aged <55 years to 41.9% among patients aged ≥85 years
(Table 1). There were 208358 (33.8%) patients with a final diagnosis of STEMI,
325299 (52.8%) NSTEACS, 24320 (3.9%) unconfirmed ACS, 35783 (5.8%) non-
ACS / other, and 19217 (3.1%) with a missing final diagnosis.
Cardiovascular risk factors
The distribution of baseline risk factors varied by age groups and sex (Table 1). Older
patients were less often current smokers and more often had hypertension, prior AMI,
angina, chronic heart failure and chronic renal failure. Compared with men ≥85 years,
women ≥85 years of age were less often current smokers. They less often had
diabetes, previous AMI, angina, previous revacularisation (PCI or CABG) and
chronic renal failure.
Diagnoses, presentation and provision of care
Table 2 shows the distribution of initial and final diagnoses, method of presentation
and provision of care by age group. Younger patients more often had an initial
diagnosis of STEMI. Older patients more often had a final diagnosis of NSTEACS.
Compared with men ≥85 years of age, women ≥85 years of age less often had an
initial diagnosis of NSTEACS. Older patients were less likely to call the emergency
services or make their own way to the hospital, and more likely to have an ACS in
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hospital than their younger counterparts. Also, older patients were less likely to be
admitted to the Cardiac Care Unit, a Cardiology ward, and be under the care of a
Consultant Cardiologist. For STEMI and NSTEMI, the proportion of patients ≥85
years of age with cardiogenic shock was higher than that for patients <55 years of age,
STEMI: <55 years, ≥85 years = 2.1%, 5.0%, P<0.001: NSTEMI: <55 years, ≥85
years = 1.2%, 3.1%, P<0.001.
Management and in-hospital mortality
Table 3 shows the distribution of evidence-based management and outcomes by age
category. For all ACS combined, older patients had greater lengths of stay (df=5,
P<0.001) and higher in-hospital mortality rates (P<0.001). For those with an initial
diagnosis of STEMI, older patients were less likely to receive primary PCI, pre-
hospital thrombolysis, and to a lesser extent in-hospital thrombolysis. They too had
greater lengths of stay (df=5, P<0.001) and higher in-hospital mortality rates (df=5,
P<0.001). Patients ≥85 years of age with an initial diagnosis of STEMI were up to
75% less likely to be reperfused (by either primary PCI or thrombolysis) compared
with those <55 years of age with STEMI: RR=0.27, 95% CI: 0.25-0.28).
For patients with AMI (STEMI or NSTEMI), the risk (RR, 95% CI) of being
prescribed aspirin (0.54, 0.53-0.56), clopidogrel (0.59, 0.57-0.62), β blockers (0.38,
0.37-0.39), statins (0.41, 0.40-0.42) or ACE inhibitors (0.50, 0.49-0.51) was
considerably lower for those ≥85 years of age with AMI compared with those <55
year of age with AMI. The elderly were less likely to undergo coronary angiography
(df=5, P<0.001) and echocardiography (df=5, P<0.001), and had greater lengths of
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stay (df=5, P<0.001) and higher in-hospital mortality rates (P<0.001) than their
younger counterparts (Table 4).
Risk of STEMI and in-hospital mortality
For males and less so females, increasing age predicted a lower risk of a final
diagnosis of STEMI (males ≥85 years OR=0.33, 95% CI: 0.32-0.34; females ≥85
years OR=0.62, 95% CI: 0.60-0.65). For both sexes, the risk of in-hospital mortality
increased with age for STEMI (males OR=20.31, 95% CI: 17.97-22.95; females
OR=14.98, 95% CI: 12.44-18.03) and NSTEMI (males OR=18.10, 95% CI: 16.05-
20.41; females OR=13.47, 95% CI: 11.27-16.08). The highest risk of death occurred
in males ≥85 years old with STEMI (OR=20.31, 95% CI: 17.97-22.95).
Year of admission and ACS care
For patients with AMI, the proportion with cardiogenic shock increased between 2003
and 2010: <55 years of age: 0.6% (2003) to 1.7% (2010), RR=2.80, 95% CI: 1.79-
4.32, P<0.001; ≥85 years of age: 1.6% (2003) to 3.1% (2010), RR=2.00, 95% CI:
1.36-2.89, P<0.001. For patients with an admission diagnosis of STEMI, rates of
primary PCI increased from 1.6% in 2003 to 60.9% in 2010 (RR=92.41, 95% CI:
71.11-120.99, P<0.001) for patients aged <55 years and from 0.2% to 48.5%
(RR=376.79, 95% CI: 140.18-1412.26, P<0.001) in patients aged ≥85 years. For
patients with AMI, there were significant increases in the rates of use of evidence-
based pharmacological therapies rates from 2003 to 2010 (Table 5).
Year of admission and in-hospital mortality
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For patients with STEMI, in-hospital mortality reduced from 2.0% in 2003 to 1.5% in
2010 (RR=0.72, 95% CI: 0.39-1.25, P=0.24) for patients aged <55 years, from 4.0%
to 1.6% (RR=0.28, 95% CI: 0.14-0.52, P<0.001) for patients aged 55-64 years, from
19.6% to 10.6% (RR=0.47, 95% CI: 0.36-0.60, P<0.001) for patients aged 75-84
years, and from 30.1% to 19.4% (RR=0.54, 95% CI: 0.38-0.75, P<0.001) in patients
aged ≥85 years (Table 5). For patients with NSTEMI, in-hospital mortality reduced
from 1.9% in 2003 to 0.9% in 2010 (RR=0.89, 95% CI: 0.48-1.34, P=0.43) for
patients aged <55 years, from 3.5% to 1.8% (RR=0.40, 95% CI: 0.23-0.65, P=0.001)
for patients aged 55-64 years, from 19.6% to 10.6% (RR=0.49, 95% CI: 0.39-0.61,
P=0.001) for patients aged 75-84, and from 31.5% to 20.4% (RR=0.56, 95% CI: 0.42-
0.73, P<0.001) in patients aged ≥85 years (Table 5). These findings were upheld after
multi-level adjustment (base = 2003, adjusted odds ratio for age group, diabetes,
hypertension, previous AMI, angina, previous revascularization, chronic heart failure,
reperfusion (primary PCI or thrombolysis) during admission, admitting ward,
admitting consultant, with hospital random intercept effects.): male STEMI 2010
OR=0.60, 95% CI: 0.48-0.75, female STEMI 2010 OR=0.55, 95% CI: 0.42-0.71,
male NSTEMI OR=0.50, 95% CI: 0.42-0.60, female NSTEMI OR=0.49, 95% CI:
0.40-0.59. After adjustment for final diagnosis and hospital-level effects, there was a
reduction in in-patient mortality from 2003 to 2010 across all age groups including
patients ≥85 years of age: OR, 95% CI; 2004: 0.94, 0.88-1.01; 2010: 0.52, 0.44-0.61,
75-84 years of age 2004: 0.98, 0.93-1.03; 2010: 0.52, 0.45-0.60, and patients <55
years of age: 2004: 0.94, 0.79-1.13; 2010: 0.64, 0.44-0.93 (Figure 1).
Discussion
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Despite earlier research from Europe which has highlighted the need to address age-
dependent inequalities in ACS quality of care 2, when compared to their younger
counterparts the elderly hospitalized with an ACS continue to be disadvantaged. This
is important when the old comprise over a third of the ACS admissions in England
and Wales. Yet, there was good evidence to suggest that all age groups including the
old and very old have benefited from improvements in ACS management – for AMI,
there were substantial year-on-year reductions in in-hospital mortality. Notably, the
temporal improvements in the risk of in-hospital mortality were similar for males and
females, and for STEMI and NSTEMI.
To date, many studies have described the differential presentation, management and
outcome of elderly versus young ACS patients 2,24-28. This research corroborates these
findings; revealing that the profile of the elderly hospitalized with an ACS has not
changed greatly. What has changed is the reduction in in-hospital mortality. We refute
findings from a recent single centre observational study which suggested that no
temporal improvements in mortality rates were evident for the elderly who underwent
primary PCI 29. Our research readily highlights that although age-dependent biases in
quality of care exist, in England and Wales significant improvements in ACS care
have occurred. From 2003 to 2010, improvements in the application of evidence-
based ACS care were evident across all age groups – this is despite the increased
proportion of patients presenting with cardiogenic shock. The unadjusted risk of in-
hospital mortality after an ACS admission in 2010 was half that of 2003 (RR=0.50,
95% CI: 0.45-0.54).
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Several studies have suggested that improvements in hospital care for the elderly
would reduce elderly ACS mortality rates 2,24-28. Our analyses using contemporary
MINAP data demonstrate this association. The reductions in in-hospital mortality
over time were unlikely to be due to reduction in lengths of hospital stay. For STEMI
and NSTEMI, we found no significant relationships between the length of hospital
stay and in-hospital mortality and there was no significant interaction between the
length of hospital stay and in-hospital mortality by year of hospital admission.
Furthermore, from 2003 to 2010, 30-day mortality rates fell for STEMI (RR=0.43,
95% CI: 0.34-0.54, P<0.001) and NSTEMI (RR=0.66, 95% CI: 0.55-0.78, P<0.001)
suggesting that the reduction in in-hospital mortality rates were unlikely to be related
to hasty (or inappropriate) discharge from hospital care. It is possible, however, that
some of the improvements in NSTEMI mortality rates related to a lower risk profile in
later years: the median (IQR) troponin concentration for NSTEMI decreased from
0.57 (2.80) in 2003 to 0.48 (2.56), P < 0.001.
Whilst the adjusted risk of the temporal decline in in-hospital mortality for STEMI
and NSTEMI <55 years of age were statistically significant, we found there was only
a non-significant trend in the decline of the absolute risk (20% and 47% respectively)
in this group. In 2003, mortality rates in the young were already low (2.0%) and it is
possible that in-hospital mortality rates lower than 1.6% (2010) are now reaching a
‘plateau of achievable care’ 30,31, and that a statistically significant association would
require much greater numbers of patients or evaluation of survival beyond the hospital
stay.
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Overall our findings are in keeping with international advances in the provision of
evidence-based acute cardiac care. They herald the accomplishment in England and
Wales of the NSF for Coronary Heart disease (2000-2010) 15. This was a nationwide
implementation strategy of changes to the delivery of care for patients with coronary
heart disease and encouraged the adoption of the translation of contemporary
evidence into best practice 20,32. Nevertheless, our research continues to support a
notion of age-dependent inequality in ACS care and moreover, highlights gaps in key
aspects of the management of elderly patients with ACS who benefit equally as much
as their younger counterparts from an early invasive strategy 28,33,34.
This study provides evidence for opportunities for improvements in the quality of
clinical care. For example, despite high frequencies of previous AMI in the very
elderly, they had previously less often undergone revascularisation when advanced
age alone must not be considered a contraindication to performing coronary
angiography and PCI 34. Overall rates of emergency reperfusion (primary PCI and
thrombolysis) for STEMI in those <55 years of age were nearly a third higher than for
those aged ≥85 years. For those with a final diagnosis of AMI, older patients were
less likely to be discharged on aspirin, clopidogrel, β blockers, ACE inhibitors, and
statins. In light of our evidence for increased risk of early mortality and greater
lengths of hospital stay, the application of evidence-base ACS therapies to appropriate
patients regardless of age may further reduce overall cost and improve early outcomes
2.
The causes for discrepancies in quality care for the elderly are multifactorial. In part,
the shortfalls in treatment may be due to the lack of appropriate specialist care and
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inappropriate placement within the hospital 35. Although the MINAP database
includes data relating to the indication, contra-indication, refusal of treatments (all
taken into account in the analyses), we were unable to evaluate the appropriateness of
ACS management 36. Reductions in risk of in-patient death may be related to
improved primary 37 and secondary prevention 38, however we specifically considered
in-hospital mortality (rather than longer-term survival) because this more clearly
reflects acute care associated with the index admission. Nonetheless, improvements in
mortality are associated with the application of evidence-based medicine 38, and it is
likely that the implementation of strategic networks of care (such as the national
primary PCI service in England and Wales 20) has contributed to the greater
application of ACS treatments and hence better outcomes 39.
Not withstanding age-dependent inequalities in care, the elderly are more likely to
present differently and less likely to have the same diagnosis on discharge from
hospital as that which they were given on admission. In our study, the risk of a change
in diagnosis from that on admission to a different one on discharge in patients ≥85
years of age was over 10% greater than for patients <55 years of age: RR, 95% CI
1.12, 1.09-1.16. Multi-level adjustment made little difference to the risk of in-hospital
mortality and suggests that the ‘diagnosis’ per se is a stronger predictor of outcome
than the covariates modelled. As such, mechanisms to improve the early and accurate
diagnosis of specific ACS subgroups in the elderly are needed so that timely risk-
evaluated ACS interventions may be implemented. It is plausible that Physicians
already know that the likelihood of an elderly patient presenting with STEMI is much
lower than that of a younger patient, and that this influences their perception of a
diagnosis of STEMI in an older patient. Finally, age-dependent inequalities in
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treatments may be the legacy of a risk–adverse strategy to ACS care 4 through lack of
accurate estimation of ACS risk 40.
Limitations
MINAP does not collect data on all patients in England and Wales and it is possible
that patients entered into the MINAP database differ from those not recorded. We
noted that data missingness for age was 4.3 % and for final diagnosis 3.2%. Although
this may introduce systematic bias, we have previously noted that whilst being
statistically significant the inclusion of missing data does not alter regional
standardised mortality ratios 41. As with all observational data, the modelling of
diagnosis, in-hospital mortality and effect of year considered hospital-level and
patient-specific influences and the use of alternative covariates may change the effect
sizes demonstrated. Finally, this research reveals important associations but cannot
prove causation.
Conclusion
The elderly comprise a substantial proportion of ACS admissions. They have a
different risk factor and ACS diagnosis profile to younger patients. Biases in elderly
ACS care remain and the elderly have significantly longer hospital lengths of stay and
higher in-hospital mortality rates. Despite this, improvements in the application of
evidence-based ACS care were evident across all age groups from 2003 to 2010.
18
There were significant year-on-year reductions in in-hospital mortality equally across
all age groups, both sexes and for STEMI and NSTEMI.
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Table 1. Baseline clinical characteristics MINAP patients (all ACS diagnoses combined) by age group
Age group (years) <55, % (n) 55-64, % (n) 65-74, % (n) 75-84, % (n) ≥85, % (n) Totals, % (n)
Men 81310 86660 94668 85741 30464 395464
Women 21105 27816 48164 68391 42257 217513
Diabetes Men 10.1 (8224) 14.3 (12412) 19.9 (18878) 19.8 (16953) 15.7 (4771) 16.1 (63592)
Women 13.6 (2867) 16.2 (4508) 20.7 (9962) 19.0 (12986) 13.6 (5742) 17.2 (37507)
Hypertension Men 27.2 (22086) 37.3 (32315) 43.7 (41378) 45.9 (39394) 44.0 (13403) 38.9 (153969)
Women 31.0 (6534) 42.2 (11751) 48.9 (23535) 52.3 (35768) 49.2 (20777) 46.9 (102094)
Current smoker Men 52.6 (42791) 36.6 (31748) 20.9 (19762) 10.9 (9361) 6.2 (1880) 27.7 (109362)
Women 47.4 (10009) 36.1 (10032) 21.5 (10349) 10.9 (7452) 3.6 (1534) 18.8 (40955)
Prior AMI Men 15.2 (12324) 20.9 (18135) 28.1 (26591) 33.3 (28525) 35.0 (10668) 25.3 (100186)
Women 11.9(2504) 15.5 (4307) 21.6 (10420) 26.4 (18078) 27.1 (11440) 22.3 (48541)
Angina Men 15.4 (12498) 23.2 (20123) 32.2 (30460) 39.1 (33525) 42.2 (12860) 28.8 (113935)
Women 17.0 (3592) 23.2 (6462) 30.3 (14594) 35.5 (24272) 35.9 (15150) 30.7 (66725)
Prior revascularization Men 10.4 (8429) 14.1 (12246) 17.2 (16313) 14.5 (12390) 6.7 (2053) 13.5 (53520)
Women 7.8 (1641) 10.0 (2786) 11.4 (5505) 8.2 (5642) 3.0 (1288) 8.0 (17506)
Chronic heart failure Men 1.1 (890) 2.3 (1961) 4.8 (4543) 8.4 (7202) 12.1 (3686) 4.8 (19060)
Women 1.3 (273) 2.4 (665) 5.0 (2418) 8.9 (6053) 12.4 (5237) 7.0 (15252)
Chronic renal failure Men 1.1 (869) 1.7 (1514) 3.7 (3456) 6.8 (5795) 9.5 (2901) 3.8 (15216)
Women 1.5 (325) 2.0 (544) 3.2 (1559) 4.8 (3307) 5.8 (2450) 3.9 (8558)
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Table 2. Initial and final ACS diagnoses, method of presentation and provision of care by age group
Age group
<55,
% (n)
55-64,
% (n)
65-74,
% (n)
75-84,
% (n)
≥85,
% (n)
Missing age,
% (n)
Totals,
% (n)
Men 81310 86660 94668 85741 30464 16621 395464
Women 21105 27816 48164 68391 42257 9780 217513
Initial diagnosis
STEMI Men 37.8 (30709) 35.6 (30841) 27.7 (26265) 20.1 (17250) 13.9 (4229) 19.1 (3182) 28.4 (112476)
Women 25.7 (5433) 26.8 (7458) 23.9 (11494) 19.0 (13013) 15.0 (6324) 13.8 (1345) 20.7 (45067)
NSTEACS Men 39.5 (32152) 42.8 (37123) 45.1 (42687) 44.8 (38403) 43.5 (13244) 40.5 (6734) 43.1 (170343)
Women 41.5 (8767) 44.3 (12331) 43.8 (21082) 42.1 (28824) 38.6 (16318) 37.7 (3687) 41.8 (91009)
Final diagnosis
STEMI Men 45.9 (37313) 44.3 (38376) 36.4 (34449) 28.3 (24244) 21.8 (6633) 24.7 (4113) 36.7 (145128)
Women 32.9 (6952) 34.7 (9663) 32.1 (15473) 27.9 (19106) 23.9 (10081) 20.0 (1955) 29.1 (63230)
NSTEACS Men 37.7 (30690) 45.1 (39063) 52.7 (49886) 61.3 (52541) 68.7 (20926) 51.0 (8473) 51.0 (201579)
Women 42.3 (8931) 49.3 (13706) 54.7 (26338) 60.7 (41541) 66.2 (27973) 53.5 (5231) 56.9 (123720)
Presentation and provision of care – all ACS
Called emergency services Men 50.7 (41228) 54.7 (47383) 59.7 (56475) 64.8 (55594) 68.6 (20899) 32.7 (5436) 57.4 (227015)
Women 49.7 (10488) 54.5 (15150) 59.3 (28557) 64.8 (44317) 68.1 (28784) 34.6 (3381) 60.1 (130677)
Made own way to hospital Men 25.7 (20913) 19.7 (17065) 13.3 (12621) 7.6 (6518) 4.1 (1239) 11.5 (1914) 15.2 (60270)
Women 22.7 (4785) 17.6 (4897) 11.7 (5628) 6.2 (4268) 3.4 (1434) 7.9 (774) 10.0 (21786)
Already in hospital Men 1.7 (1403) 2.5 (2184) 4.1 (3838) 6.0 (5104) 7.1 (2175) 12.6 (2096) 4.2 (16800)
Women 2.9 (615) 3.4 (952) 4.9 (2368) 6.6 (4544) 7.7 (3244) 16.1(1571) 6.1 (13294)
First ward - Cardiac Care Unit Men 66.1 (53780) 63.1 (54709) 57.2 (54318) 49.0 (42054) 38.9 (11858) 43.3 (7203) 56.6 (223922)
Women 59.1 (12471) 56.8 (15793) 52.8 (25423) 45.1 (30816) 35.1 (14823) 36.9 (3610) 47.3 (102936)
First ward: Cardiology Men 4.8 (3901) 5.5 (4779) 5.8 (5472) 5.8 (4958) 5.8 (1781) 4.7 (784) 5.5 (21675)
Women 5.0 (1056) 5.7 (1579) 5.8 (2780) 5.5 (3771) 5.2 (2193) 3.9 (375) 5.4 (11754)
Admitting Consultant: Cardiologist Men 50.1 (40729) 48.0 (41627) 44.0 (41637) 36.8 (31561) 28.5 (8689) 38.3 (6365) 43.1 (170608)
Women 47.1 (9950) 44.5 (12372) 42.0 (20229) 34.0 (23285) 25.1 (10609) 33.1 (3238) 36.6 (79683)
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Table 3. Management and outcome by age group and ACS subgroups
Age group
<55,
% (n)
55-64,
% (n)
65-74,
% (n)
75-84,
% (n)
≥85,
% (n)
Missing age,
% (n) Totals
Men 81310 86660 94668 85741 30464 16621 395464
Women 21105 27816 48164 68391 42257 9780 217513
All ACS
Median length of hospital stay (IQR) Men 4 (5) 5 (5) 6 (7) 7 (8) 7 (10) 5 (5) 5 (6)
Women 4 (5) 5 (5) 6 (6) 7 (9) 8 (11) 6 (8) 6 (8)
In-hospital mortality Men 1.3 (1070) 2.5 (2161) 5.6 (5296) 11.8 (10141) 19.7 (6004) 7.4 (1224) 6.6 (25996)
Women 1.7 (360) 3.2 (888) 6.5 (3151) 12.7 (8660) 20.3 (8570) 10.8 (1053) 10.4 (22682)
Patients with an initial diagnosis is STEMI
Primary PCI Men 24.3 (7470) 21.1 (6509) 19.5 (5123) 17.3 (2992) 15.1 (640) 8.8 (280) 20.5 (23014)
Women 23.7 (1287) 20.6 (1534) 19.3 (2223) 16.7 (2174) 13.4 (849) 6.5 (88) 18.1 (8155)
Pre-hospital thrombolysis Men 11.8 (3644) 12.9 (3973) 11.7 (3072) 7.1 (1221) 2.4 (102) 1.6 (50) 10.7 (12062)
Women 9.5 (516) 11.3 (840) 9.6 (1102) 5.6 (734) 1.7 (106) 1.3 (17) 7.4 (3315)
In hospital thrombolysis Men 52.6 (16175) 53.8 (16607) 54.3 (14253) 54.7 (9442) 52.8 (2233) 49.6 (1580) 53.6 (60290)
Women 53.7 (2920) 55.1 (4112) 54.4 (6256) 54.5 (7091) 50.2 (3172) 44.8 (603) 53.6(24154)
Median length of hospital stay (IQR) Men 4 (3) 5 (4) 5 (5) 6 (7) 6 (9) 5 (5) 5 (5)
Women 5 (4) 5 (4) 6 (5) 6 (7) 7 (10) 6 (6) 6 (7)
In-hospital mortality Men 1.5 (467) 2.6 (815) 6.2 (1625) 14.0 (2423) 24.5 (1035) 5.5 (174) 5.8 (6539)
Women 2.3 (126) 4.2 (313) 8.2 (944) 17.2 (2232) 28.9 (1827) 14.1 (189) 12.5 (5631)
Patients with a final diagnosis is AMI (NSTEMI + STEMI)
Aspirin on discharge Men 79.1(48675) 77.9 (55083) 74.6 (57505) 70.2 (50171) 66.5 (17508) 73.5 (8210) 74.5 (237152)
Women 77.0 (10690) 77.2 (16011) 74.0 (27850) 69.6 (38934) 65.5 (23562) 68.3 (4373) 77.0(214905)
Clopidogrel on discharge Men 36.7 (22566) 35.7 (25230) 32.5 (25031) 29.9 (21343) 28.5 (7509) 22.9 (2557) 32.7 (104236)
Women 36.0 (4992) 35.3 (7331) 32.0 (12048) 29.4 (16463) 25.7 (9255) 19.4 (1241) 30.1 (51330)
Β blocker on discharge Men 71.9 (44265) 68.3 (48266) 61.3 (47285) 53.6 (38327) 46.0 (12108) 60.1 (6709) 61.9(196960) 
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Women 64.3 (8925) 63.1 (13084) 58.3(21917) 53.3 (29843) 46.3 (16642) 50.7 (3249) 54.9 (93660)
ACE inhibitor on discharge Men 70.1 (43168) 69.6 (49228) 66.2 (51016) 59.4 (42504) 49.4 (13021) 61.7 (6886) 64.7 (205823)
Women 63.4 (8792) 65.4 (13565) 63.7 (23979) 58.5 (32743) 48.1 (17286) 53.4 (3421) 58.5 (99786)
Statin on discharge Men 78.4 (48261) 78.0 (55116) 75.5 (58154) 70.4 (50344) 61.3 (16131) 72.3 (8072) 74.2 (236078)
Women 76.0 (10545) 77.1 (15986 ) 74.9 (28181) 69.6 (38920) 56.2 (20224) 63.9 (4093) 69.2 (117949)
Coronary angiography Men 56.7 (34883) 51.1 (36119) 43.6 (33577) 27.5 (19654) 12.1 (3196) 34.3 (3831) 41.2 (131260)
Women 53.9 (7485) 47.5 (9850) 38.7 (14567) 22.5 (12592) 8.8 (3153) 24.0 (1535) 28.8 (49182)
Echocardiography Men 48.7 (29987) 48.9 (34557) 49.6 (38257) 48.6 (34781) 41.3 (10872) 46.4 (5182) 48.3 (153636)
Women 49.2 (6823) 48.4 (10036) 49.5 (18642) 48.2 (26941) 38.2 (13728) 42.9 (2745) 46.3 (78915)
Median length of hospital stay (IQR) Men 5 (4) 5 (5) 6 (6) 7 (8) 7 (9) 6 (5) 6 (6)
Women 5 (4) 5 (5) 6 (7) 7 (9) 8 (11) 7 (8) 7 (8)
In-hospital mortality Men 1.3 (824) 2.6 (1872) 5.6 (4506) 12.0 (8894) 19.7 (5329) 8.0 (940) 6.8 (22365)
Women 1.9 (276) 3.5 (747) 6.9 (2704) 13.2 (7674) 20.6 (7700) 12.8 (861) 11.3 (19962)
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Table 4. Association of age with risk of in-hospital all-cause mortality for STEMI and NSTEMI, by sex.
* Unadjusted odds ratio for age, with hospital random intercept effects.
** Adjusted odds ratio for age, diabetes, hypertension, previous AMI, angina, previous revascularization, chronic heart failure, reperfusion
(primary PCI or thrombolysis) during admission, admitting ward, admitting consultant, with hospital random intercept effects.
Male FemaleRisk of in-hospital
mortality Odds ratio* (95% CI) Odds ratio** (95% CI) Odds ratio* (95% CI) Odds ratio** (95% CI)
STEMI
<55 years 1.00 1.00 1.00 1.00
55-64 years 1.95 (1.76-2.15) 1.97 (1.75-2.23) 1.79 (1.51-2.14) 1.89 (1.54-2.33)
65-74 years 4.55 (4.14-4.99) 4.41 (3.94-4.94) 3.75 (3.21-4.40) 3.80 (3.14-4.59)
75-84 years 11.50 (10.51-12.59) 10.62 (9.51-11.86) 8.19 (7.03-9.54) 8.29 (6.91-9.95)
≥85 years 23.30 (21.09- 25.74) 20.31 (17.97-22.95) 15.28 (13.10-17.83) 14.98 (12.44-18.03)
NSTEMI
<55 years 1.00 1.00 1.00 1.00
55-64 years 2.00 (1.77-2.19) 2.27 (1.99-2.59) 1.78 (1.49-2.12) 1.82 (1.48-2.23)
65-74 years 4.17 (3.79- 4.59) 4.94 (4.38-5.56) 3.81 (3.26-4.46) 4.10 (3.42-4.92)
75-84 years 8.94 (8.14-9.81) 10.46 (9.31-11.75) 7.53 (6.47-8.77) 8.08 (6.77-9.64)
≥85 years 15.71 (14.27-17.28) 18.10 (16.05-20.41) 12.66 (10.88-14.74) 13.47 (11.27-16.08)
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Table 5. ACS provision of care and in-hospital mortality by year of admission
Age group Years Relative risk (95%CI)
Provision of care
2003-2004 2009-2010
Primary PCI for STEMI <55 years 3.3% 52.1% 31.57 (28.22-35.33)
>85 years 0.5% 32.2% 82.52 (55.28-128.55)
Aspirin on admission for AMI <55 years 86.5% 90.2% 1.43 (1.33-1.53)
>85 years 76.6% 86.6% 1.97 (1.85-2.11)
GP IIbIIIa for AMI <55 years 10.2 % 15.2% 1.59 (1.47-1.73)
>85 years 2.0% 2.6% 1.31 (1.08-1.59)
Aspirin on discharge for AMI <55 years 95.8% 82.5% 0.20 (0.19-0.22)
>85 years 81.1% 71.6% 0.59 (0.55-0.63)
ACE inhibitor on discharge for AMI <55 years 81.4% 76.5% 1.35 (1.27-1.42)
>85 years 57.4% 55.9% 1.06 (1.01-1.12)
Β blocker on discharge for AMI <55 years 85.5% 75.3% 0.52 (0.49-0.55) 
>85 years 49.1% 56.7% 1.35 (1.29-1.43)
Clopidogrel on discharge for AMI <55 years 56.1% 97.3% 28.48 (20.64-39.69)
>85 years 28.1% 89.1% 81.31 (59.06-112.26)
Statin on discharge for AMI <55 years 94.2% 82.4% 0.29 (0.26-0.31)
>85 years 61.3% 68.6% 1.38 (1.31-1.46)
In-hospital mortality*
2003 2010
STEMI <55 years 2.0% 1.5% 0.72 (0.39-1.25)
>85 years 30.1% 19.4% 0.54 (0.38-0.75)
NSTEMI <55 years 1.9% 0.9% 0.89 (0.48-1.34)
>85 years 31.5% 20.4% 0.56 (0.42-0.73)
*unadjusted rates
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Figure 1. Odds ratios by year for in-hospital all-cause mortality, stratified by age
category*
Odds ratio
Year
*2003 = base, adjustment for final diagnosis and hospital-level random effects.
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